glp 1 vs sglt2 GLP-1 Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs GLP-1 receptor agonists vs. SGLT-2
Description
Most of us, weve seen my parents get care within [Kaiser] Permanente
Nor did its effects deteriorate over time (Zander, Madsbad, Madsen, Holst)
Analyses based on the FDA Adverse Event Reporting System (FAERS) showed that incretin-mimetic drugs are linked with increased incidence of pancreatitis and pancreatic cancer compared with other anti-diabetic drugs [160-162]
The company now holds 22 patents with 63 more pending and has raised over $150 million from investors including Meritech Capital Partners, Sequoia Capital, Khosla Ventures, True Ventures, AME Cloud Ventures and the Mayo Clinic
Non-specific binding was defined by 100 nM of GLP-1(7-36) or human or mouse GIP(1-42)NH2
Available from: Discover CME INDIA Explore CME INDIA Repository Examine CME INDIA Case Study Read History Today in Medicine Register for Future CMEs
